GL Pharm Tech Corp. (KOSDAQ: A204840)
Health Care · Pharmaceuticals · KR
₩4,200.00
-2.78% today · -32.5% 1Y
GL Pharm Tech Corp. (KOSDAQ: A204840) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $48.45M.
Over the last twelve months the share price has lost 32.5%, trading between 3.76K and 6.65K.
Tweenvest scores GL Pharm Tech Corp. across four factors: quality 45/100, value 67/100, growth 98/100. Its strongest factor is growth.
A204840 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $48.45M
- Revenue (TTM)
- $24.67M
- P/E
- —
- EPS
- -6.92
- Dividend yield
- —
- Beta (5Y)
- 0.47
- 52-week high
- ₩6,650.00
- 52-week low
- ₩3,760.00
- Avg volume (3M)
- —
- Shares outstanding
- 15.51M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Labiana Health, S.A.BME: LAB | $49.71M | €5.25 | -1.87% |
| China NT Pharma Group Company LimitedSEHK: 1011 | $49.58M | HK$0.41 | +6.49% |
| Anya Biopharm Inc.TPEX: 7776 | $49.22M | NT$32.05 | -6.56% |
| Haleos Labs LimitedNSEI: HALEOSLABS | $48.85M | Rs1,563.70 | +4.95% |
| PharmGen Science, Inc.KOSE: A004720 | $48.11M | ₩2,860.00 | +0.35% |
| THX Pharma Société AnonymeENXTPA: ALTHX | $47.50M | €3.09 | +0.49% |
| AB Science S.A.ENXTPA: AB | $46.95M | €0.55 | +4.77% |
| Albert David LimitedBSE: 524075 | $46.62M | Rs790.65 | -7.10% |
Figures last refreshed Oct 11, 2026.